Literature DB >> 15721418

Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: a pilot study.

Anna Fagotti1, Francesco Fanfani, Manuela Ludovisi, Roberto Lo Voi, Giuseppe Bifulco, Antonia Carla Testa, Giovanni Scambia.   

Abstract

OBJECTIVE: To investigate whether laparoscopy can be considered as adequate and reliable as standard laparotomy in predicting optimal cytoreduction (RT < or = 1 cm) in patients with advanced ovarian cancer.
METHODS: From March to November 2003, 95 patients with suspected advanced ovarian or peritoneal cancer have been evaluated. Thirty-one cases were excluded due to an anesthesiological class of risk ASA III-IV (51.6%) and for the presence of a large size mass reaching the xiphoid (48.4%). Sixty-four patients completed the study. All patients were submitted to preoperative clinico-radiological evaluation and then to both laparoscopy and standard longitudinal laparotomy, sequentially. Some specific preoperatively defined parameters were analyzed during each procedure in order to obtain the most accurate evaluation on the possibility to get an optimal cytoreduction.
RESULTS: The overall accuracy rate of laparoscopy in assessing optimal cytoreduction was 90%. The negative predictive value (NPV) of the clinical-radiologic evaluation corresponded to 73%, whereas in no case was the judgment of unresectable disease obtained by laparoscopy changed by the laparotomic approach (NPV 100%). On the contrary, an optimal debulking was achievable in 34 of 39 cases (87%) selected as completely resectable by explorative laparoscopy.
CONCLUSIONS: Laparoscopy can be considered super imposable to standard longitudinal laparotomy in identifying not optimally resectable advanced ovarian cancer patients.

Entities:  

Mesh:

Year:  2005        PMID: 15721418     DOI: 10.1016/j.ygyno.2004.11.031

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  21 in total

Review 1.  Predictors of optimal cytoreduction in patients with newly diagnosed advanced-stage epithelial ovarian cancer: Time to incorporate laparoscopic assessment into the standard of care.

Authors:  Natalia Rodriguez Gómez-Hidalgo; Bertha Alejandra Martinez-Cannon; Alpa M Nick; Karen H Lu; Anil K Sood; Robert L Coleman; Pedro T Ramirez
Journal:  Gynecol Oncol       Date:  2015-03-28       Impact factor: 5.482

2.  Peritoneal carcinosis of ovarian origin.

Authors:  Anna Fagotti; Valerio Gallotta; Federico Romano; Francesco Fanfani; Cristiano Rossitto; Angelica Naldini; Massimo Vigliotta; Giovanni Scambia
Journal:  World J Gastrointest Oncol       Date:  2010-02-15

Review 3.  A framework for a personalized surgical approach to ovarian cancer.

Authors:  Alpa M Nick; Robert L Coleman; Pedro T Ramirez; Anil K Sood
Journal:  Nat Rev Clin Oncol       Date:  2015-02-24       Impact factor: 66.675

Review 4.  Prediction of optimal debulking surgery in ovarian cancer.

Authors:  Yong Jung Song
Journal:  Gland Surg       Date:  2021-03

Review 5.  Current Recommendations for Minimally Invasive Surgical Staging in Ovarian Cancer.

Authors:  Anna Fagotti; Federica Perelli; Luigi Pedone; Giovanni Scambia
Journal:  Curr Treat Options Oncol       Date:  2016-01

6.  Cost-effectiveness of laparoscopic disease assessment in patients with newly diagnosed advanced ovarian cancer.

Authors:  Ross F Harrison; Scott B Cantor; Charlotte C Sun; Mariana Villanueva; Shannon N Westin; Nicole D Fleming; Iakovos Toumazis; Anil K Sood; Karen H Lu; Larissa A Meyer
Journal:  Gynecol Oncol       Date:  2021-01-31       Impact factor: 5.482

7.  The safety and efficacy of laparoscopic surgical staging and debulking of apparent advanced stage ovarian, fallopian tube, and primary peritoneal cancers.

Authors:  Farr R Nezhat; Shaghayegh M DeNoble; Connie S Liu; Jennifer E Cho; Douglas N Brown; Linus Chuang; Herbert Gretz; Prakash Saharia
Journal:  JSLS       Date:  2010 Apr-Jun       Impact factor: 2.172

8.  Early port-site metastasis during neoadjuvant chemotherapy in advanced stage ovarian cancer: report of two cases.

Authors:  Batuhan Ozmen; Yavuz Emre Sükür; Cem Somer Atabekoglu; Aylin Okçu Heper; Murat Sönmezer; Mete Güngör
Journal:  J Gynecol Oncol       Date:  2011-03-31       Impact factor: 4.401

9.  Laparoscopy to predict the result of primary cytoreductive surgery in advanced ovarian cancer patients (LapOvCa-trial): a multicentre randomized controlled study.

Authors:  Marianne J Rutten; Katja N Gaarenstroom; Toon Van Gorp; Hannah S van Meurs; Henriette Jg Arts; Patrick M Bossuyt; Henk G Ter Brugge; Ralph Hm Hermans; Brent C Opmeer; Johanna Ma Pijnenborg; Henk Wr Schreuder; Eltjo Mj Schutter; Anje M Spijkerboer; Celesta Wm Wensveen; Petra Zusterzeel; Ben Willem J Mol; Gemma G Kenter; Marrije R Buist
Journal:  BMC Cancer       Date:  2012-01-20       Impact factor: 4.430

10.  Neoadjuvant chemotherapy or primary surgery for stage III/IV ovarian cancer: contribution of diagnostic laparoscopy.

Authors:  Jean-Luc Brun; Roman Rouzier; Frédéric Selle; Sidney Houry; Serge Uzan; Emile Daraï
Journal:  BMC Cancer       Date:  2009-06-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.